Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ENDO 2018Micronized Progesterone for Hot Flashes in Perimenopause Oral bioidentical progesterone is a good option for treating hot flashes and night sweats during perimenopause, according to the first randomized controlled trial to specifically examine this issue.
Medscape Medical News, March 21, 2018
ENDO 2018Once-Daily 'Male Pill' Shows Promise in Early Study In a 28-day study, oral dimethandrolone undecanoate significantly lowered testosterone levels without causing 'low T' symptoms, offering the tantalizing prospect of a male contraceptive pill.
Medscape Medical News, March 19, 2018
ENDO 2018The LDL Dilemma in Diabetes: How Low Do You Go? Two heavyweights go head to head on what is the optimal LDL-cholesterol level in patients with diabetes, given recent clinical trial data.
'Bioidentical' Oral Alternative to Compound Hormones on HorizonNew oral fixed-dose combinations of 17-? estradiol and natural progesterone are being developed that, if approved, will offer
a regulated alternative to compounded hormonal therapy for menopause symptoms.
Medscape Medical News, Apr 10, 2017
Abaloparatide Best in 'Really High-Risk' Osteoporosis PatientsAs anticipated US approval for a new anabolic agent, abaloparatide, for osteoporosis is delayed by 3 months, one expert discussed
how he thinks the agent will best fit into the armamentarium.
Medscape Medical News, Apr 6, 2017
Are Flame Retardants Driving Some of Thyroid Cancer Increase?In an innovative study that analyzed house dust to determine concentrations of flame-retardant chemicals, researchers have
linked certain ones to a higher risk of papillary thyroid cancer.
